<?xml version="1.0" encoding="UTF-8"?>
<results title="binomial">
 <result pre="nd vapor phases is reported. Methods: The activity of TTO was tested against methicillin-sensitive " exact="Staphylococcus aureus" xpath="/html[1]/body[1]/div[4]/div[6]/div[1]/div[1]/p[1]" match="Staphylococcus aureus" post=" (MSSA), Escherichia coli, and clinical strains of methicillin-resistant S. aureus (M" name="binomial"/>
 <result pre=" The activity of TTO was tested against methicillin-sensitive Staphylococcus aureus (MSSA), " exact="Escherichia coli" xpath="/html[1]/body[1]/div[4]/div[6]/div[1]/div[1]/p[1]" match="Escherichia coli" post=", and clinical strains of methicillin-resistant S. aureus (MRSA), extended-spectrum beta lac" name="binomial"/>
 <result pre="lococcus aureus (MSSA), Escherichia coli, and clinical strains of methicillin-resistant " exact="S. aureus" xpath="/html[1]/body[1]/div[4]/div[6]/div[1]/div[1]/p[1]" match="Staphylococcus aureus" post=" (MRSA), extended-spectrum beta lactamases producer carbapenem-sensitive Klebsiella pneumoniae&lt;/" name="binomial"/>
 <result pre="resistant S. aureus (MRSA), extended-spectrum beta lactamases producer carbapenem-sensitive " exact="Klebsiella pneumoniae" xpath="/html[1]/body[1]/div[4]/div[6]/div[1]/div[1]/p[1]" match="Klebsiella pneumoniae" post=" (ESBL-CS-Kp), carbapenem-resistant K. pneumoniae (CR-Kp), Acinetobacter baumannii (C" name="binomial"/>
 <result pre="ases producer carbapenem-sensitive Klebsiella pneumoniae (ESBL-CS-Kp), carbapenem-resistant " exact="K. pneumoniae" xpath="/html[1]/body[1]/div[4]/div[6]/div[1]/div[1]/p[1]" match="Klebsiella pneumoniae" post=" (CR-Kp), Acinetobacter baumannii (CR-Ab), and Pseudomonas aeruginosa (CR-Pa). Minima" name="binomial"/>
 <result pre="tive Klebsiella pneumoniae (ESBL-CS-Kp), carbapenem-resistant K. pneumoniae (CR-Kp), " exact="Acinetobacter baumannii" xpath="/html[1]/body[1]/div[4]/div[6]/div[1]/div[1]/p[1]" match="Acinetobacter baumannii" post=" (CR-Ab), and Pseudomonas aeruginosa (CR-Pa). Minimal inhibitory/bactericidal concentrations" name="binomial"/>
 <result pre="p), carbapenem-resistant K. pneumoniae (CR-Kp), Acinetobacter baumannii (CR-Ab), and " exact="Pseudomonas aeruginosa" xpath="/html[1]/body[1]/div[4]/div[6]/div[1]/div[1]/p[1]" match="Pseudomonas aeruginosa" post=" (CR-Pa). Minimal inhibitory/bactericidal concentrations (MIC/MBCs) and synergistic activity betwee" name="binomial"/>
 <result pre=" Therefore, TTO could represent the basis for a possible role in non-conventional regimens against " exact="S. aureus" xpath="/html[1]/body[1]/div[4]/div[6]/div[1]/div[1]/p[1]" match="Staphylococcus aureus" post=" and Gram-negative MDR. TTO in VP might represent a promising option for local therapy of pneumonia" name="binomial"/>
 <result pre="l and effective antimicrobial agents in the pipeline, especially against carbapenem-resistant (CR) " exact="Acinetobacter baumannii" xpath="/html[1]/body[1]/div[4]/div[6]/div[1]/div[1]/p[1]" match="Acinetobacter baumannii" post=" and CR Enterobacteriaceae carrying enzymes other than class A carbapenemases [ &lt;a href=&quot;#B2" name="binomial"/>
 <result pre="Tea tree oil (TTO) is produced by steam distillation of leaves and terminal branches of " exact="Melaleuca alternifolia" xpath="/html[1]/body[1]/div[4]/div[6]/div[1]/div[1]/p[1]" match="Melaleuca alternifolia" post=" and is currently used in traditional medicine as a topical antiseptic and anti-inflammatory agent " name="binomial"/>
 <result pre="antimicrobials, such as vancomycin [ 15] and aminoglycosides for " exact="S. aureus" xpath="/html[1]/body[1]/div[4]/div[6]/div[1]/div[1]/p[1]" match="Staphylococcus aureus" post=" and E. coli [ 16] and, recently, combined with different " name="binomial"/>
 <result pre="as vancomycin [ 15] and aminoglycosides for S. aureus and " exact="E. coli" xpath="/html[1]/body[1]/div[4]/div[6]/div[1]/div[1]/p[1]" match="Escherichia coli" post=" [ 16] and, recently, combined with different nanoparticles [ &lt;a " name="binomial"/>
 <result pre="rcial TTO, alone and in combination with different antimicrobials, against methicillin-susceptible " exact="Staphylococus aureus" xpath="/html[1]/body[1]/div[4]/div[6]/div[1]/div[1]/p[1]" match="Staphylococus aureus" post=" (MSSA), methicillin-resistant Staphylococus aureus (MRSA), Escherichia coli and MDR " name="binomial"/>
 <result pre="robials, against methicillin-susceptible Staphylococus aureus (MSSA), methicillin-resistant " exact="Staphylococus aureus" xpath="/html[1]/body[1]/div[4]/div[6]/div[1]/div[1]/p[1]" match="Staphylococus aureus" post=" (MRSA), Escherichia coli and MDR Gram-negative bacteria including extended-spectrum beta la" name="binomial"/>
 <result pre="ible Staphylococus aureus (MSSA), methicillin-resistant Staphylococus aureus (MRSA), " exact="Escherichia coli" xpath="/html[1]/body[1]/div[4]/div[6]/div[1]/div[1]/p[1]" match="Escherichia coli" post=" and MDR Gram-negative bacteria including extended-spectrum beta lactamases (ESBLs) producer carbap" name="binomial"/>
 <result pre="egative bacteria including extended-spectrum beta lactamases (ESBLs) producer carbapenem-sensitive " exact="Klebsiella pneumoniae" xpath="/html[1]/body[1]/div[4]/div[6]/div[1]/div[1]/p[1]" match="Klebsiella pneumoniae" post=" (ESBL-CS-Kp), ESBL and carbapenem-resistant K. pneumoniae (CR-Kp), carbapenem-resistant " name="binomial"/>
 <result pre="ucer carbapenem-sensitive Klebsiella pneumoniae (ESBL-CS-Kp), ESBL and carbapenem-resistant " exact="K. pneumoniae" xpath="/html[1]/body[1]/div[4]/div[6]/div[1]/div[1]/p[1]" match="Klebsiella pneumoniae" post=" (CR-Kp), carbapenem-resistant Acinetobacter baumannii (CR-Ab) and carbapenem-resistant P" name="binomial"/>
 <result pre="/i&gt; (ESBL-CS-Kp), ESBL and carbapenem-resistant K. pneumoniae (CR-Kp), carbapenem-resistant " exact="Acinetobacter baumannii" xpath="/html[1]/body[1]/div[4]/div[6]/div[1]/div[1]/p[1]" match="Acinetobacter baumannii" post=" (CR-Ab) and carbapenem-resistant Pseudomonas aeruginosa (CR-Pa). In addition, the antibacte" name="binomial"/>
 <result pre=" (CR-Kp), carbapenem-resistant Acinetobacter baumannii (CR-Ab) and carbapenem-resistant " exact="Pseudomonas aeruginosa" xpath="/html[1]/body[1]/div[4]/div[6]/div[1]/div[1]/p[1]" match="Pseudomonas aeruginosa" post=" (CR-Pa). In addition, the antibacterial effectiveness of TTO in the VP against the abovementioned " name="binomial"/>
 <result pre=" against a list of standard and clinical isolate strains of important microorganisms such as MSSA, " exact="E. coli" xpath="/html[1]/body[1]/div[4]/div[6]/div[1]/div[1]/p[1]" match="Escherichia coli" post=", MRSA, ESBL-CS-Kp, CR-Ab, and CR-Pa. AMK, CFZ, MEM, OXA, COL, RIF and VAN were used as references " name="binomial"/>
 <result pre="gainst all the tested Gram-negative microorganisms, with MIC/MBCs 0.25%/0.25% for CR-Ab, CR-Kp and " exact="E. coli" xpath="/html[1]/body[1]/div[4]/div[6]/div[1]/div[1]/p[1]" match="Escherichia coli" post=", 1%/1% for CR-Pa, 0.5%/0.5% for ESBL-CS-Kp. With regard to MSSA and MRSA, MIC/MBCs were 1%/2% and " name="binomial"/>
 <result pre="mpound activity. DD experiments showed a higher potency of TTO against Gram-negative bacteria than " exact="S. aureus" xpath="/html[1]/body[1]/div[4]/div[6]/div[1]/div[1]/p[1]" match="Staphylococcus aureus" post=". Regarding VP assays, the in-vitro effectiveness of TTO in VP was lower than that by DD analysis; " name="binomial"/>
 <result pre=" present study the antimicrobial activity of a commercial formulation of TTO was evaluated against " exact="S. aureus" xpath="/html[1]/body[1]/div[4]/div[6]/div[1]/div[1]/p[1]" match="Staphylococcus aureus" post=" and several MDR Gram-negative bacteria. " name="binomial"/>
 <result pre="th absence of bacterial growth at concentrations ranging from 0.25% to 0.5% v/ v for " exact="E. coli" xpath="/html[1]/body[1]/div[4]/div[6]/div[1]/div[1]/p[1]" match="Escherichia coli" post=", ESBL-CS-Kp, CR-Ab, and CR-Kp whereas a lower bactericidal activity (1% v/ v) was fo" name="binomial"/>
 <result pre="tible to TTO at concentrations of 1.0% or less and higher MICs were reported for organisms such as " exact="P. aeruginosa" xpath="/html[1]/body[1]/div[4]/div[6]/div[1]/div[1]/p[1]" match="Pseudomonas aeruginosa" post=" [ 13]. " name="binomial"/>
 <result pre="erved with the disk diffusion analysis (liquid phase), antibacterial activity was retained against " exact="E. coli" xpath="/html[1]/body[1]/div[4]/div[6]/div[1]/div[1]/p[1]" match="Escherichia coli" post=" and both CS and CR-Kp whereas no activity was found with regard to MSSA, MRSA, and CR-Pa. Interest" name="binomial"/>
 <result pre="ble to be reduced from 64 to 2 Î¼g/mL its MIC, being OXA one of the more active beta-lactam against " exact="S. aureus" xpath="/html[1]/body[1]/div[4]/div[6]/div[1]/div[1]/p[1]" match="Staphylococcus aureus" post=" but to which MRSA is typically resistant [ 39]. Killing studies " name="binomial"/>
 <result pre="4-ol compared to the other components was found active against all tested microorganisms including " exact="Escherichia coli" xpath="/html[1]/body[1]/div[4]/div[6]/div[1]/div[1]/p[1]" match="Escherichia coli" post=", Candida albicans, and Staphylococcus aureus. In the present study, the direct compa" name="binomial"/>
 <result pre="r components was found active against all tested microorganisms including Escherichia coli, " exact="Candida albicans" xpath="/html[1]/body[1]/div[4]/div[6]/div[1]/div[1]/p[1]" match="Candida albicans" post=", and Staphylococcus aureus. In the present study, the direct comparison of the two analyses" name="binomial"/>
 <result pre=" against all tested microorganisms including Escherichia coli, Candida albicans, and " exact="Staphylococcus aureus" xpath="/html[1]/body[1]/div[4]/div[6]/div[1]/div[1]/p[1]" match="Staphylococcus aureus" post=". In the present study, the direct comparison of the two analyses (liquid and VP) indicated a marke" name="binomial"/>
 <result pre="For antimicrobial activity determination, we used the following microorganisms: MSSA (ATCC 29213), " exact="E. coli" xpath="/html[1]/body[1]/div[4]/div[6]/div[1]/div[1]/p[1]" match="Escherichia coli" post=" (ATCC 25922), MRSA (clinical strain isolated from skin), ESBL-CS-Kp (clinical strain isolated from" name="binomial"/>
 <result pre="ynergism of the following combinations: TTO + AMK/CFZ/OXA/VAN/RIF for MSSA/MRSA; TTO + AMK/MEM for " exact="E. coli" xpath="/html[1]/body[1]/div[4]/div[6]/div[1]/div[1]/p[1]" match="Escherichia coli" post="; TTO + MEM/COL for CR-Ab; TTO + MEM/AMK/COL for CR-Pa; TTO + AMK/MEM/COL for ESBL-CS-Kp and CR-Kp." name="binomial"/>
 <result pre=" diffusion ( panel A) and vapor phase ( panel B) activity of TTO. MSSA: Methicillin-susceptibility " exact="Staphylococcus aureus" xpath="/html[1]/body[1]/div[4]/div[6]/div[1]/div[1]/p[1]" match="Staphylococcus aureus" post="; MRSA: Methicillin-resistant Staphylococcus aureus; ESBL: Extended Spectrum Beta-Lactamases" name="binomial"/>
 <result pre="of TTO. MSSA: Methicillin-susceptibility Staphylococcus aureus; MRSA: Methicillin-resistant " exact="Staphylococcus aureus" xpath="/html[1]/body[1]/div[4]/div[6]/div[1]/div[1]/p[1]" match="Staphylococcus aureus" post="; ESBL: Extended Spectrum Beta-Lactamases; CS: Carbapenem-Susceptible; CR: Carbapenem-Resistant; Kp" name="binomial"/>
 <result pre="ESBL: Extended Spectrum Beta-Lactamases; CS: Carbapenem-Susceptible; CR: Carbapenem-Resistant; Kp: " exact="Klebsiella pneumoniae" xpath="/html[1]/body[1]/div[4]/div[6]/div[1]/div[1]/p[1]" match="Klebsiella pneumoniae" post="; Ab: Acinetobacter baumannii; Pa: Pseudomonas aeruginosa. " name="binomial"/>
 <result pre="mases; CS: Carbapenem-Susceptible; CR: Carbapenem-Resistant; Kp: Klebsiella pneumoniae; Ab: " exact="Acinetobacter baumannii" xpath="/html[1]/body[1]/div[4]/div[6]/div[1]/div[1]/p[1]" match="Acinetobacter baumannii" post="; Pa: Pseudomonas aeruginosa. " name="binomial"/>
 <result pre="R: Carbapenem-Resistant; Kp: Klebsiella pneumoniae; Ab: Acinetobacter baumannii; Pa: " exact="Pseudomonas aeruginosa" xpath="/html[1]/body[1]/div[4]/div[6]/div[1]/div[1]/p[1]" match="Pseudomonas aeruginosa" post=". " name="binomial"/>
 <result pre="different concentrations throughout killing study. GC: Growth Control; MRSA: Methicillin-resistant " exact="Staphylococcus aureus" xpath="/html[1]/body[1]/div[4]/div[6]/div[1]/div[1]/p[1]" match="Staphylococcus aureus" post=". Dashed line represents bactericidal activity. " name="binomial"/>
 <result pre="centrations against MRSA throughout killing study. GC: Growth Control; MRSA: Methicillin-resistant " exact="Staphylococcus aureus" xpath="/html[1]/body[1]/div[4]/div[6]/div[1]/div[1]/p[1]" match="Staphylococcus aureus" post="; OXA: oxacillin. Dashed line represents bactericidal activity. " name="binomial"/>
 <result pre="Antibacterial activity of TTO and different antimicrobials against MSSA, MRSA, " exact="Escherichia coli" xpath="/html[1]/body[1]/div[4]/div[6]/div[1]/div[1]/p[1]" match="Escherichia coli" post=", ESBL-CS-Kp, ESBL-CR-Kp, CR-Ab, and CR-Pa. " name="binomial"/>
 <result pre="tion; 10: Minimal Bactericidal Concentration; 11: Methicillin-susceptibility " exact="Staphylococcus aureus" xpath="/html[1]/body[1]/div[4]/div[6]/div[1]/div[1]/p[1]" match="Staphylococcus aureus" post="; 12: Methicillin-resistant Staphylococcus aureus; 13: Escherichia " name="binomial"/>
 <result pre="up&gt;: Methicillin-susceptibility Staphylococcus aureus; 12: Methicillin-resistant " exact="Staphylococcus aureus" xpath="/html[1]/body[1]/div[4]/div[6]/div[1]/div[1]/p[1]" match="Staphylococcus aureus" post="; 13: Escherichia coli; 14: Extended Spectrum Beta-Lactamases; 15" name="binomial"/>
 <result pre="ccus aureus; 12: Methicillin-resistant Staphylococcus aureus; 13: " exact="Escherichia coli" xpath="/html[1]/body[1]/div[4]/div[6]/div[1]/div[1]/p[1]" match="Escherichia coli" post="; 14: Extended Spectrum Beta-Lactamases; 15: Carbapenem-Susceptible; 16&lt;" name="binomial"/>
 <result pre="p&gt;: Carbapenem-Susceptible; 16: Kp; 17: Carbapenem-Resistant; 18: " exact="Acinetobacter baumannii" xpath="/html[1]/body[1]/div[4]/div[6]/div[1]/div[1]/p[1]" match="Acinetobacter baumannii" post="; 19: Pseudomonas aeruginosa; 20: Not Active. " name="binomial"/>
 <result pre="17: Carbapenem-Resistant; 18: Acinetobacter baumannii; 19: " exact="Pseudomonas aeruginosa" xpath="/html[1]/body[1]/div[4]/div[6]/div[1]/div[1]/p[1]" match="Pseudomonas aeruginosa" post="; 20: Not Active. " name="binomial"/>
 <result pre="gistic activity by FICI * values of TTO combined with different antimicrobials against MSSA, MRSA; " exact="Escherichia coli" xpath="/html[1]/body[1]/div[4]/div[6]/div[1]/div[1]/p[1]" match="Escherichia coli" post=", ESBL-CS-Kp, ESBL-CR-Kp, CR-Ab, and CR-Pa. " name="binomial"/>
 <result pre="fampin; 7: meropenem; 8: colistin.; 9: Methicillin-susceptibility " exact="Staphylococcus aureus" xpath="/html[1]/body[1]/div[4]/div[6]/div[1]/div[1]/p[1]" match="Staphylococcus aureus" post="; 10: Methicillin-resistant Staphylococcus aureus; 11: Escherichia " name="binomial"/>
 <result pre="up&gt;: Methicillin-susceptibility Staphylococcus aureus; 10: Methicillin-resistant " exact="Staphylococcus aureus" xpath="/html[1]/body[1]/div[4]/div[6]/div[1]/div[1]/p[1]" match="Staphylococcus aureus" post="; 11: Escherichia coli; 12: Extended Spectrum Beta-Lactamases; 13" name="binomial"/>
 <result pre="ccus aureus; 10: Methicillin-resistant Staphylococcus aureus; 11: " exact="Escherichia coli" xpath="/html[1]/body[1]/div[4]/div[6]/div[1]/div[1]/p[1]" match="Escherichia coli" post="; 12: Extended Spectrum Beta-Lactamases; 13: Carbapenem-Susceptible; 14&lt;" name="binomial"/>
 <result pre="p&gt;: Carbapenem-Susceptible; 14: Kp; 15: Carbapenem-Resistant; 16: " exact="Acinetobacter baumannii" xpath="/html[1]/body[1]/div[4]/div[6]/div[1]/div[1]/p[1]" match="Acinetobacter baumannii" post="; 17: Pseudomonas aeruginosa; 18: Not Applicable. " name="binomial"/>
 <result pre="15: Carbapenem-Resistant; 16: Acinetobacter baumannii; 17: " exact="Pseudomonas aeruginosa" match="Pseudomonas aeruginosa" post="; 18: Not Applicable. " name="binomial"/>
</results>
